Ginkgo Bioworks Holdings, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-0.86 | — | Miss |
| Q12026 FY2026 | — | $-1.28 | — | Miss |
| Q42025 FY2025 | $-1.80 | $-1.42 | +21.1% | Beat |
Back to DNA overview · DNA holders · DNA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.